|Day Low/High||3.91 / 4.06|
|52 Wk Low/High||3.70 / 8.77|
Walgreen shareholders are likely to do well whatever happens with the company's multi-billion dollar merger with Rite-Aid.
We are building up on Nucor after initiating the position yesterday.
Another big rally made for a day of milestones: the Dow and S&P 500 enjoyed their best back-to-back gains of the year, while the Nasdaq scored a new record.
Better-than-expected earnings from industry leaders including Caterpillar and McDonald's push the Dow to log triple-digit gains for the second day in a row, its best two-day stretch of the year.
A stream of positive earnings reports keep stocks on the rise on Tuesday with the Dow Jones Industrial Average logging triple-digit gains for the second day in a row.
Analysts were expecting the company to report a four cent per share loss for the quarter.
Stock futures move higher on Tuesday, extending gains seen a day earlier, after a series of positive earnings results from the likes of DuPont, Novartis, and Rite Aid.
Rite Aid Corporation (NYSE:RAD) today reported operating results for its fourteen week fourth quarter and fifty-three week fiscal year ended March 4, 2017.
Earnings and hopes for a tax plan help lift the markets. Portfolio moves include exiting a utility position.
Market rumors of an FTC lawsuit are hitting the shares of Rite Aid, Fred's and, to a lesser extent, Walgreens.
Stocks end at session lows as an earnings disappointment from IBM weighs on the Dow Jones Industrial Average and a crude selloff pressures the energy sector.
Earlier market optimism faded as Wednesday wore on and a financials rally gave way to a selloff in Dow Jones Industrial Average component IBM and energy shares.
The S&P 500 hugs the flatline on Wednesday afternoon as a selloff in crude oil prices and energy shares counters better-than-expected earnings from Morgan Stanley.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer breaks down the day's trending stocks on our daily Facebook Live show, which airs weekdays at 10 a.m. EST.
Syria missile strike and U.S. jobs report cap a rugged week for markets. We make several portfolio moves, including a downgrade.
Sycamore Partners' attempt to purchase divested dollar stores went poorly. Will the FTC believe Fred's can do better with Rite Aid spinoffs?
The two companies initially agreed to an acquisition agreement in October 2015.
We will be watching for levels near $80, where we become interested in increasing our weighting.
Be it a failed merger or finally approved by regulators, Jim Cramer just wants something to happen on the Walgreens-Rite Aid deal.
TheStreet's Jim Cramer said he wants the Walgreens Boots Alliance WBA merger with Rite Aid RAD deal to close or fall apart soon.
Rite Aid is proud to announce the two winners of this year's Vote for Your Favorite Pharmacy Team Member Contest.
With 4,600 stores chainwide, Rite Aid is ready to help Easter Bunnies deliver an eggstra-special holiday this season.
TheStreet's Jim Cramer discusses the hottest stocks of the day on our daily Facebook Live show, airing weekdays at 10 a.m. EST.
The amazing first quarter didn't rely just on Trump.
Walgreens has been waiting for approval for its $9.7 billion bid for Rite Aid since 2014.